Mission
The mission of the Scleroderma Research Foundation is to fund and facilitate the most promising, highest quality research aimed at new treatments and, ultimately, a cure for scleroderma.
Public Charity
Scleroderma Research Foundation
Scleroderma Research Foundation, of San Francisco, CA, is a Public Charity tracked in Imperigo's IRS 990 database. The 2024 filing shows $12.2M in revenue, $9.6M in expenses, $33.0M in total assets. 95 publicly reported grants to this organization, totaling roughly $5.0M, appear in IRS filings.
EIN: 680087234
San Francisco, CA
Latest filing: 2024
Total Revenue$12.2M
Total Expenses$9.6M
Total Assets$33.0M
Grant Records95
Funding Total$5.0M
Filing Years2020–2024
Sample Grants Received
For grant recipient's exempt purposes
$670,030
FOR GENERAL AND PROJECT SUPPORT
$111,000
PROGRAMATIC SUPPORT
$77,000
PROGRAMATIC SUPPORT
$77,000
MEDICAL RESEARCH
$45,000
Showing up to 5 of 95 total records — full history available with membership.
Officers & Directors
Board Member
David Knoller
Treasurer
Deann Wright
Board Member
Eric Kau Md
VP Communications
Gloria Blecha
Chief Medical Officer
Gregory Gordon
Dir. Communication
Hannah Young
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $12.2M | $9.6M | $33.0M |
| 2023 | $8.4M | $6.5M | $18.7M |
| 2022 | $5.9M | $4.7M | $11.1M |
| 2021 | $3.8M | $3.7M | $9.8M |
| 2020 | $3.9M | $3.0M | $9.6M |
Between 2020 and 2024, reported annual revenue grew from $3.9M to $12.2M (+210%), with total assets most recently reported at $33.0M.
Interactive year-over-year charts and full filing details available with membership.